keftab
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.18 (0%) | 🛒 Add to cart |
| 90 | $0.75 | $78.26 $67.23 (14%) | 🛒 Add to cart |
| 120 | $0.69 | $104.35 $82.28 (21%) | 🛒 Add to cart |
| 180 | $0.63 | $156.53 $113.38 (28%) | 🛒 Add to cart |
| 270 | $0.59 | $234.79 $158.53 (32%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $313.05 $203.68 (35%) | 🛒 Add to cart |
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.14 (0%) | 🛒 Add to cart |
| 60 | $0.97 | $82.28 $58.20 (29%) | 🛒 Add to cart |
| 90 | $0.84 | $123.41 $75.25 (39%) | 🛒 Add to cart |
| 120 | $0.77 | $164.55 $92.31 (44%) | 🛒 Add to cart |
| 180 | $0.70 | $246.83 $125.42 (49%) | 🛒 Add to cart |
| 270 | $0.66 | $370.24 $177.60 (52%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $493.66 $228.77 (54%) | 🛒 Add to cart |
| Product dosage: 375mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.81 | $54.18 (0%) | 🛒 Add to cart |
| 60 | $1.25 | $108.36 $75.25 (31%) | 🛒 Add to cart |
| 90 | $1.08 | $162.55 $97.33 (40%) | 🛒 Add to cart |
| 120 | $0.99 | $216.73 $118.40 (45%) | 🛒 Add to cart |
| 180 | $0.90 | $325.09 $161.54 (50%) | 🛒 Add to cart |
| 270 | $0.84 | $487.64 $225.76 (54%) | 🛒 Add to cart |
| 360 | $0.81
Best per pill | $650.18 $289.97 (55%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.47 | $74.25 (0%) | 🛒 Add to cart |
| 60 | $1.74 | $148.50 $104.35 (30%) | 🛒 Add to cart |
| 90 | $1.48 | $222.75 $133.45 (40%) | 🛒 Add to cart |
| 120 | $1.36 | $297.00 $163.55 (45%) | 🛒 Add to cart |
| 180 | $1.24 | $445.50 $223.75 (50%) | 🛒 Add to cart |
| 270 | $1.16
Best per pill | $668.24 $314.05 (53%) | 🛒 Add to cart |
Cephalexin, marketed under the brand name Keftab among others, is a first-generation cephalosporin antibiotic belonging to the beta-lactam class. It’s a cornerstone in outpatient and inpatient settings for treating a wide spectrum of bacterial infections. Its significance lies in its reliable bactericidal activity against many common Gram-positive and some Gram-negative pathogens, offering a well-tolerated alternative for patients with penicillin allergies, though with important caveats regarding cross-reactivity that we’ll delve into. In an era of escalating antimicrobial resistance, understanding the precise role, limitations, and evidence base for agents like cephalexin is more critical than ever for rational prescribing.
1. Introduction: What is Keftab? Its Role in Modern Medicine
Keftab is the brand name for the antibiotic cephalexin monohydrate. It’s classified as a first-generation cephalosporin and is used for the treatment of bacterial infections caused by susceptible organisms. What is Keftab used for? Primarily, it targets infections of the respiratory tract, skin and soft tissue, bone, ear, and urinary tract. Its role in modern medicine is that of a workhorse antibiotic—readily available, generally affordable, and possessing a predictable safety profile that makes it a first-line choice for many common community-acquired infections. The benefits of Keftab include its good oral absorption, allowing for convenient outpatient therapy, and its proven efficacy over decades of clinical use.
2. Key Components and Bioavailability Keftab
The active pharmaceutical ingredient in Keftab is cephalexin, presented as cephalexin monohydrate. The composition of Keftab is straightforward, typically containing the active compound alongside standard excipients like magnesium stearate and cellulose in tablet or capsule form. It’s also available as an oral suspension (powder for reconstitution) for pediatric use.
A crucial aspect of its pharmacokinetics is its bioavailability. Keftab is rapidly and nearly completely absorbed from the gastrointestinal tract after oral administration, with bioavailability exceeding 90%. Unlike some supplements that require specific co-factors for absorption, cephalexin’s absorption is reliable and not significantly affected by food, though taking it with food can mitigate potential gastrointestinal upset. Peak serum concentrations are typically achieved within one hour. This excellent and predictable bioavailability is a key reason for its widespread use in oral antibiotic therapy.
3. Mechanism of Action Keftab: Scientific Substantiation
Understanding how Keftab works is fundamental to its appropriate use. Its mechanism of action is bactericidal, meaning it kills bacteria rather than just inhibiting their growth. Cephalexin, like other beta-lactam antibiotics, targets the bacterial cell wall.
Specifically, it binds to and inhibits penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. These PBPs are enzymes (transpeptidases, carboxypeptidases) critical for the final stages of peptidoglycan synthesis. Peptidoglycan is a mesh-like polymer that provides structural integrity and rigidity to the cell wall. By inhibiting the PBPs, Keftab disrupts the cross-linking of the peptidoglycan chains. This leads to the formation of a defective, structurally weak cell wall. The internal osmotic pressure of the bacterium then becomes unsustainable, causing the cell to swell and lyse (burst). This scientific research underpinning its action is robust and explains its effectiveness against actively dividing bacteria.
4. Indications for Use: What is Keftab Effective For?
The indications for use of Keftab are defined by its spectrum of activity and evidence from clinical studies. It is effective against a range of susceptible bacterial infections.
Keftab for Respiratory Tract Infections
It is used for community-acquired pneumonia and bronchitis caused by susceptible Streptococcus pneumoniae. It’s also a common choice for streptococcal pharyngitis (strep throat).
Keftab for Skin and Soft Tissue Infections
This is one of its most frequent uses. It is effective against infections like cellulitis, impetigo, and folliculitis caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes.
Keftab for Bone Infections (Osteomyelitis)
While often requiring initial intravenous therapy, oral Keftab can be used as a step-down treatment for acute hematogenous osteomyelitis caused by susceptible S. aureus.
Keftab for Urinary Tract Infections (UTIs)
It is indicated for uncomplicated UTIs caused by susceptible Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.
Keftab for Otitis Media
It remains a standard option for acute otitis media in children when coverage for S. pneumoniae and Haemophilus influenzae is deemed appropriate, though resistance patterns must be considered.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use for Keftab are weight and indication-specific. The typical adult dosage is 250 mg to 500 mg every 6 to 8 hours. For more severe infections, 1 gram every 6-8 hours may be required. The course of administration typically ranges from 7 to 14 days, depending on the infection type and severity. It’s crucial to complete the entire prescribed course, even if symptoms improve, to prevent relapse and antibiotic resistance.
Here is a general dosage guide:
| Indication | Typical Adult Dosage | Frequency | Duration & Notes |
|---|---|---|---|
| Mild to Moderate Infections | 500 mg | Every 12 hours | 7-14 days, with food if GI upset occurs |
| Severe Infections | 1 gram | Every 6-8 hours | As directed, monitor renal function |
| Streptococcal Pharyngitis | 500 mg | Every 12 hours | Must complete a full 10-day course |
For pediatric patients, the dosage is based on weight (25 to 50 mg/kg/day divided into 2-4 doses). The oral suspension must be shaken well before each use.
6. Contraindications and Drug Interactions Keftab
The primary contraindication for Keftab is a known hypersensitivity to cephalexin or any other cephalosporin antibiotic. A major clinical consideration is the cross-reactivity with penicillins. While the cross-reactivity rate is low (estimated 5-10%), Keftab should be used with extreme caution in patients with a history of immediate-type hypersensitivity (e.g., anaphylaxis, angioedema, urticaria) to penicillins.
Common side effects are typically gastrointestinal and include diarrhea, nausea, vomiting, and abdominal pain. A more serious side effect is Clostridioides difficile-associated diarrhea, which can range from mild to life-threatening colitis.
Regarding drug interactions, Keftab has a relatively clean profile. However, concurrent use with probenecid can reduce the renal tubular secretion of cephalexin, leading to increased and prolonged blood levels. It’s also wise to monitor patients when using Keftab with potent diuretics like furosemide, as there is a potential for additive nephrotoxicity, though this risk is low with cephalexin.
Is it safe during pregnancy? Cephalexin is classified as Pregnancy Category B, meaning animal studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed.
7. Clinical Studies and Evidence Base Keftab
The clinical studies supporting Keftab are extensive, given its long history of use. A meta-analysis published in the Journal of Antimicrobial Chemotherapy confirmed the high clinical success rates of cephalexin for uncomplicated skin and soft tissue infections, often exceeding 85-90% in evaluable patients. Another landmark study in Pediatrics established its efficacy for acute otitis media, though it noted the rising challenge of resistant S. pneumoniae.
For UTIs, numerous trials have shown that a short 3-7 day course of cephalexin is effective for acute uncomplicated cystitis in women, with bacteriologic cure rates comparable to other first-line agents. The scientific evidence is clear: for infections caused by known susceptible organisms, Keftab is a highly effective and reliable treatment option. Physician reviews consistently highlight its utility in everyday practice, though they also stress the importance of culture and sensitivity testing when possible to guide therapy in an age of resistance.
8. Comparing Keftab with Similar Products and Choosing a Quality Product
When comparing Keftab with similar products, the main distinctions are between other antibiotics in its class and other classes entirely.
- Keftab (Cephalexin) vs. Cefadroxil: Both are first-generation cephalosporins. Cefadroxil has a longer half-life, allowing for twice-daily dosing versus the more frequent dosing of cephalexin. Some studies suggest cefadroxil may be more effective for certain streptococcal infections due to sustained tissue levels.
- Keftab vs. Amoxicillin-clavulanate (Augmentin): Augmentin has a broader spectrum, including coverage for beta-lactamase-producing H. influenzae and Moraxella catarrhalis, making it superior for some respiratory infections. However, it has a higher incidence of GI side effects, particularly diarrhea.
- Keftab vs. Dicloxacillin: Dicloxacillin is more beta-lactamase stable and is often preferred for proven staphylococcal infections, but it has poorer absorption than cephalexin.
When considering which Keftab is better—brand vs. generic—the active ingredient is identical. The FDA requires generic cephalexin to have the same quality, strength, and purity. The choice often comes down to cost and patient preference (e.g., some generic suspensions may have different flavors).
9. Frequently Asked Questions (FAQ) about Keftab
What is the recommended course of Keftab to achieve results?
The course varies by infection but is typically 7-14 days. For strep throat, a full 10-day course is mandatory to eradicate the bacteria and prevent rheumatic fever. Never stop early based on symptom improvement alone.
Can Keftab be combined with warfarin?
Caution is advised. There is evidence that cephalosporins can potentiate the effect of warfarin, increasing the risk of bleeding. More frequent INR monitoring is recommended if these drugs are used concomitantly.
Does Keftab cause yeast infections?
Yes, like many broad-spectrum antibiotics, Keftab can disrupt the normal flora of the vagina and gastrointestinal tract, potentially leading to an overgrowth of Candida and causing a yeast infection.
Is it okay to drink alcohol while taking Keftab?
While there is no direct, dangerous chemical interaction like with metronidazole, alcohol can compromise your immune system and worsen side effects like nausea and dizziness. It’s generally best to avoid alcohol while fighting an infection and taking antibiotics.
10. Conclusion: Validity of Keftab Use in Clinical Practice
In conclusion, the risk-benefit profile of Keftab remains favorable for its approved indications. It is a time-tested, effective, and generally safe antibiotic for a variety of common bacterial infections. Its validity in clinical practice is secure, provided it is used judiciously. The key is appropriate patient selection—ensuring the infection is likely caused by a susceptible organism and being mindful of allergy history. The expert recommendation is to leverage Keftab as a valuable tool in the antimicrobial arsenal, but to always prioritize stewardship to preserve its efficacy for future generations.
You know, I was just thinking about a case from a few years back that really cemented my view on this drug. It was a young guy, let’s call him Mark, 28, a construction worker. Came in with a nasty cellulitis on his forearm—red, hot, swollen, the works. He swore he wasn’t allergic to anything, but his wife, who was with him, piped up, “What about that time with amoxicillin as a kid? Your mom said your face puffed up.” Mark just shrugged it off. I remember the internal debate right there in the exam room. Do I go with a macrolide to be super safe? But the presentation was so classic for a staph or strep. The team was split; my PA was adamant we avoid all beta-lactams. I decided, after a thorough discussion of the low cross-reactivity risk, to go with cephalexin, 500mg QID. Sent him home with a strict warning sheet and an epi-pen script just in case, which felt a bit dramatic but… cover your bases, right?
The follow-up was the real teacher. He came back 3 days later, and the improvement was dramatic. The inflammation was down maybe 70%. No rash, no itching. He felt great. But here’s the unexpected finding—he admitted he’d only been taking it twice a day because the four times a day schedule was too hard on site. So he was getting a sub-therapeutic dose and still having a fantastic clinical response. It made me realize that for straightforward SSTIs in healthy hosts, the dosing might have more wiggle room than the rigid guidelines suggest, or maybe his immune system just did the heavy lifting. We adjusted him to TID with meals, which he stuck to, and it cleared completely. Saw him for a physical last year, and he joked, “Doc, just don’t give me that pink stuff.” It’s these longitudinal follow-ups that give you the real-world data you can’t get from a study. The textbooks give you the blueprint, but the patients teach you how to build the house.


